Hercules Technology's Kathy Conte to be Featured Speaker at Association of Bioscience Financial Officers (ABFO) Event

PALO ALTO, Calif.--(BUSINESS WIRE)--

Hercules Technology Growth Capital, Inc. (NASDAQ:HTGC), the premier specialty finance company providing venture debt and equity to venture capital and private equity backed technology and life science companies at all stages of development, today announced that Kathy Conte, managing director of life sciences, will be one of three featured speakers at the Association of Bioscience Financial Officers (ABFO) dinner. The event will take place tomorrow, from 6-9 p.m. PT, at the Hotel Sofitel in Redwood Shores, Calif.

Ms. Conte will use her extensive experience working with bioscience companies to discuss financing vehicles available to help companies reach the next important milestone.

Featured alongside Ms. Conte will be Jim Scopa, managing director at MPM Capital and Dan Spiegelman, senior vice president and chief financial officer at CV Therapeutics, Inc.

ABFO was established in 1988 by senior financial executives working in the bioscience industry in order to provide a forum for the discussion of business and financial issues specifically relevant to the bioscience industry. ABFO started in Northern California and has since grown into a national organization. The Northern California Chapter (NorCal) serves the San Francisco Bay Area and surrounding areas.

About Hercules Technology Growth Capital, Inc.:

Hercules Technology Growth Capital, Inc. is a NASDAQ traded specialty finance company providing debt and equity growth capital to technology and life science companies at all stages of development. Founded in December 2003, the company primarily finances privately held companies backed by leading venture capital and private equity firms. Hercules invests in a broad range of ventures active in technology and life science industries and offers a full suite of growth capital products at all levels of the capital structure. The company is headquartered in Palo Alto, Calif. and has additional offices in the Boston, Boulder, San Diego, Columbus and Chicago areas. Providing capital to publicly-traded or privately-held companies backed by leading venture capital and private equity firms involves a high degree of credit risk and may result in potential losses of capital. For more information, please visit www.HTGC.com.

Companies interested in learning more about financing opportunities should contact info@HTGC.com, or call 650.289.3060.

Forward-Looking Statements:

The statements contained in this release that are not purely historical are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements including, without limitation, the risks, uncertainties and other factors we identify from time to time in our filings with the Securities and Exchange Commission. Although we believe that the assumptions on which these forward-looking statements are reasonable, any of those assumptions could prove to be inaccurate and, as a result, the forward-looking statements based on those assumptions also could be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made as of the date hereof, and Hercules assumes no obligation to update the forward-looking statements for subsequent events.

Source: Hercules Technology Growth Capital, Inc.

Released May 19, 2008